Expert Video - What is comprehensive biomarker testing for lung cancer? What do I need to know?

Dr. Shanda Blackmon, director of cancer surgery from The Lung Institute at Baylor College of Medicine, explains what comprehensive biomarker testing for lung cancer is and what you need to know. She describes how comprehensive biomarker testing looks to identify specific genetic markers, or molecular markers, that may indicate the presence of a specific type of cancer that can be treated. If the genetic markers identified have known treatments available, these can be used to treat your lung cancer in situations where traditional treatments may not work. If you are interested in having comprehensive biomarker testing, Dr. Blackmon recommends you have a conversation with your medical oncologist about this topic since every institution is different, and frequently there are many clinical trials that patients can enroll into that cover the cost of molecular testing.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Patient Stories: